M. Ricciardi

Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions.

S. Tsigkos, Matthias P. Hofer, Maria E Sheean, 2018, Drug discovery today.

Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort

A. Ruiz, M. Boada, L. Tárraga, 2023, Frontiers in Neuroscience.

The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment

A. Ruiz, M. Boada, L. Tárraga, 2023, International journal of molecular sciences.

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

A. Ruiz, M. Boada, L. Tárraga, 2023, Scientific Reports.

Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

A. Ruiz, M. Boada, L. Tárraga, 2023, Frontiers in neuroscience.

Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort

L. Tárraga, A. Espinosa, S. Diego, 2024, Alzheimer's research & therapy.